Crystal Egg Bio
Crystalo Biopharma (深圳晶蛋生物医药科技有限公司) is a biopharmaceutical company founded in August 2019, dedicated to developing drugs for neurological and psychiatric diseases, chronic kidney diseases, and cardiovascular diseases. Their mission is to develop drugs with extremely low side effects by precisely targeting ion channels. The company has a core team of PhDs from renowned research institutions and pharmaceutical companies, with Nobel laureate Erwin Neher serving as Chief Scientific Advisor. They have achieved significant milestones, including winning innovation awards and completing over 100 million RMB in financing. Crystalo Biopharma is a leader in discovering new ion channel targets, activity testing, and structure-based and AI-driven drug development, positioning itself to be a globally influential enterprise in the field.
Crystal Egg Bio
Crystalo Biopharma (深圳晶蛋生物医药科技有限公司) is a biopharmaceutical company founded in August 2019, dedicated to developing drugs for neurological and psychiatric diseases, chronic kidney diseases, and cardiovascular diseases. Their mission is to develop drugs with extremely low side effects by precisely targeting ion channels. The company has a core team of PhDs from renowned research institutions and pharmaceutical companies, with Nobel laureate Erwin Neher serving as Chief Scientific Advisor. They have achieved significant milestones, including winning innovation awards and completing over 100 million RMB in financing. Crystalo Biopharma is a leader in discovering new ion channel targets, activity testing, and structure-based and AI-driven drug development, positioning itself to be a globally influential enterprise in the field.